Qube Research & Technologies Ltd

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 1729829 LONDON, X0

Position in FENC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$626,639

+$445,965 QoQ

Shares Held

58,292

+98.4% QoQ

Ownership

0.166%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#32

of 104 holders

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. FENC ranks #124 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$626,639	58,292	+98.4%	Shares	Sole	2026-08-14
2026-03-31	$180,674	29,378	-34.3%	Shares	Sole	2026-05-15
2025-12-31	$344,128	44,692	+103.7%	Shares	Sole	2026-02-17
2024-12-31	$138,648	21,938	-55.0%	Shares	Sole	2025-02-14
2024-09-30	$243,570	48,714	+3.7%	Shares	Sole	2024-11-14
2024-06-30	$287,071	46,984	+428.9%	Shares	Sole	2024-08-14
2024-03-31	$98,790	8,884	-77.9%	Shares	Sole	2024-05-14
2023-03-31	$334,422	40,195	+132.7%	Shares	Sole	2023-05-15
2022-12-31	$165,811	17,272	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.